Arizona Revised Statutes

Ariz. Rev. Stat. § 36-2601 (2026)

Definitions

✓ text as last checked Oct. 2026 (this copy records no edition or section history)
Find cases: SyfertCases citing this section AZ-LEGazleg.gov (official) JustiaTitle on Justia CornellLII Search CasesGoogle Scholar

36-2601. Definitions

In this article, unless the context otherwise requires:

1. "Board" means the Arizona state board of pharmacy or its designee.

2. "Dispenser" means a medical practitioner or pharmacy that is authorized to dispense controlled substances.

3. "Licensed health care provider" means a person who is licensed pursuant to title 32, chapter 7, 11, 13, 14, 15, 16, 17, 18, 19.1, 25, 29 or 33.

4. "Medical practitioner" means any person who is licensed and authorized by law to use and prescribe drugs and devices to treat sick and injured human beings or to diagnose or prevent sickness in human beings in this state or any state, territory or district of the United States.

5. "Patient utilization report" means all of the following information about a patient that is compiled by the program and disclosed pursuant to section 36-2606:

(a) Controlled substances prescription monitoring program data.

(b) Clinical alerts and other required alerts or indicators.

6. "Person" means an individual, partnership, corporation or association and the person's duly authorized agents.

7. "Program" means the controlled substances prescription monitoring program.

Notes of Decisions
Cited in 1 case, 1992–1992 · leading case: State v. Cramer, 851 P.2d 147 (Ariz. Ct. App. 1992).
State v. Cramer, 851 P.2d 147 (Ariz. Ct. App. 1992). · cites it 2× “This conclusion is confirmed, the state contends, by the Legislature’s refusal to renew the controlled substances therapeutic research act, A.R.S. §§ 36-2601 to 36-2606, which expired July 1, 1985.”
Annotations are extracted automatically from the opinions in the Syfert caselaw corpus and ranked by authority, recency, and treatment. Dots show Syfertize treatment of the citing case itself.